Researcher
Conny Gysemans
- Disciplines:Endocrinology and metabolic diseases
Affiliations
- Clinical and Experimental Endocrinology (Division)
Member
From1 Oct 1999 → Today
Projects
1 - 10 of 17
- Neutrophils: neglected as potential players in autoimmune type 1 diabetes initiation, progression, and perpetuationFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- "SyneRegIm": exploring the SYNErgistic effect of β-cell REGeneration and emerging IMmune intervention strategies to prevent and/or reverse type 1 diabetesFrom1 Sep 2022 → TodayFunding: Foreign private sponsor - undefined
- Characterization of the dynamic immunophenotype during type 1 diabetes progression to identify predictive biomarkers of anti-CD3 mono- and combination therapy in disease prevention and reversal in miceFrom7 Aug 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Antigen-specific peripheral tolerization and targeted delivery as preventive strategy in mice with late-stage pre-diabetesFrom1 Jan 2021 → TodayFunding: FWO research project (including WEAVE projects)
- Single cell RNA and small non-coding RNA sequencing to identify biomarkers for pathogenesis and therapy response in type 1 diabetes.From1 Jan 2019 → 31 Dec 2022Funding: FWO research project (including WEAVE projects)
- MULTI-OMICS TECHNOLOGIES TO IDENTIFY BIOMARKERS FOR THERAPY PREDICTION AND RESPONSE IN TYPE 1 DIABETESFrom19 Nov 2018 → 7 Nov 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- The beta-cell and the immune system in type 1 diabetes: partners in crime - developing new therapies in type 1 diabetes through better understanding of beta-cell behaviour and use of novel immunomodulators.From1 Oct 2018 → TodayFunding: BOF - projects, Fund Recuperation Fiscal Exemption
- Is PFKFB4 a metabolic checkpoint controlling 1,25(OH)2D3-modulated dendritic cell (DC) tolerogenicity?From1 Jan 2015 → 31 Dec 2017Funding: FWO research grant KAN
- Prediction of pregnancy outcomes in women with gestational diabetes and their risk to develop diabetes postpartum.From1 Jan 2014 → 31 Dec 2017Funding: FWO research project (including WEAVE projects)
- Diabetes reversal in NOD mice by L.lactis-based Ag therapy in combination with low dose anti-CD3.From1 Oct 2013 → 30 Sep 2014Funding: BOF - Other initiatives
Publications
1 - 10 of 138
- HAMSAB diet ameliorates dysfunctional signaling in pancreatic islets in autoimmune diabetes(2024)
Authors: Conny Gysemans
- Neutrophils: a driving force in type 1 diabetes?(2023)
Authors: Samal Bissenova, Chantal Mathieu, Conny Gysemans
- Footprint of pancreas infiltrating and circulating immune cells throughout type 1 diabetes development(2023)
Authors: Gabriele Sassi, Chantal Mathieu, Conny Gysemans
- MULTI-OMICS TECHNOLOGIES TO IDENTIFY BIOMARKERS FOR THERAPY PREDICTION AND RESPONSE IN TYPE 1 DIABETES(2023)
Authors: Gabriele Sassi, Chantal Mathieu, Conny Gysemans
- A Plasma miR-193b-365 Signature Combined With Age and Glycemic Status Predicts Response to Lactococcus lactis-Based Antigen-Specific Immunotherapy in New-Onset Type 1 Diabetes(2023)
Authors: Gabriele Sassi, Amber Wouters, Pierre Lemaitre, Samal Bissenova, Conny Gysemans
- High-Throughput Analysis of Neutrophil Extracellular Trap Le of People with Type 1 Diabetes(2023)
Authors: Samal Bissenova, Markus Bösch, Hannelie Korf, Kristina Casteels, An Teunkens, Chantal Mathieu, Conny Gysemans
- NET Proteome in Established Type 1 Diabetes Is Enriched in Metabolic Proteins(2023)
Authors: Samal Bissenova, Rita Derua, Chantal Mathieu, Conny Gysemans, Lut Overbergh
- Neutrophils in autoimmunity: when the hero becomes the villain(2022)
Authors: Samal Bissenova, Chantal Mathieu, Conny Gysemans
Pages: 128 - 140 - Preventing type 1 diabetes in late-stage pre-diabetic NOD mice with insulin: A central role for alum as adjuvant(2022)
Authors: Pieter-Jan Martens, Ylke Bruggeman, Chantal Mathieu, Conny Gysemans
- High Serum Vitamin D Concentrations, Induced via Diet, Trigger Immune and Intestinal Microbiota Alterations Leading to Type 1 Diabetes Protection in NOD Mice(2022)
Authors: Pieter-Jan Martens, Gabriele Sassi, Lieve Verlinden, Mieke Verstuyf, Jeroen Raes, Chantal Mathieu, Conny Gysemans
Patents
1 - 4 of 4
- Biomarkers for diabetes therapy (Inventor)
- Biomarkers for diabetes therapy (Inventor)
- Improved methods for pancreatic islet transplantation (Inventor)
- Improved methods for pancreatic islet transplantation (Inventor)